Eriko Yasuda
Papers
2
Total Citations
60
H-Index
2
About
Dr. Eriko Yasuda is a leading figure in the development of mass spectrometry-based diagnostics for lysosomal storage disorders, with a particular focus on mucopolysaccharidoses (MPS). Her pioneering work has centered on creating high-throughput, automated assays for the precise quantification of glycosaminoglycans (GAGs)—the complex sugars whose accumulation drives MPS pathology. Her landmark 2014 study introduced a novel heparan sulfate assay using automated high-throughput mass spectrometry, a method that has become foundational for both monitoring disease progression and newborn screening, accumulating 36 citations. This work, alongside her 2014 paper on tandem mass spectrometry applications for MPS diagnosis (24 citations), has directly improved the speed and accuracy of detecting these devastating enzyme deficiencies. By enabling earlier intervention, Dr. Yasuda’s contributions have had a tangible impact on patient outcomes, transforming how clinicians screen for and manage MPS. Her research remains a critical resource for laboratories worldwide, bridging the gap between analytical chemistry and clinical care.
Research Focus
Key Achievements
Top Papers
- 1
- 2